Skip to main content

and
  1. Article

    Open Access

    In Vitro ADME and Preclinical Pharmacokinetics of Ulotaront, a TAAR1/5-HT1A Receptor Agonist for the Treatment of Schizophrenia

    Ulotaront (SEP-363856) is a TAAR1 agonist with 5-HT1A agonist activity currently in clinical development for the treatment of schizophrenia. The objectives of the current study were to characterize the in vitro A...

    Guangqing **ao, Yu-Luan Chen, Nina Dedic, Linghong **e in Pharmaceutical Research (2022)